XML 78 R66.htm IDEA: XBRL DOCUMENT v3.24.3
Derivative Liabilities (Details) - Schedule of Derivative Liability Warrants Outstanding - Derivative Liability Warrants [Member]
9 Months Ended
Sep. 30, 2024
$ / shares
shares
Schedule of Derivative Liability Warrants Outstanding [Line Items]  
Outstanding | shares 306,828
Weighted average exercise price | $ / shares $ 2.5
April 27, 2027 [Member]  
Schedule of Derivative Liability Warrants Outstanding [Line Items]  
Outstanding | shares 75,840
Expiry date Apr. 27, 2027 [1]
Weighted average exercise price | $ / shares $ 2.01
April 27, 2027 [Member]  
Schedule of Derivative Liability Warrants Outstanding [Line Items]  
Outstanding | shares 63,037
Expiry date Apr. 27, 2027 [1]
Weighted average exercise price | $ / shares $ 2.01
April 27, 2027 [Member]  
Schedule of Derivative Liability Warrants Outstanding [Line Items]  
Outstanding | shares 80,388
Expiry date Apr. 27, 2027 [1]
Weighted average exercise price | $ / shares $ 2.01
April 27, 2027 [Member]  
Schedule of Derivative Liability Warrants Outstanding [Line Items]  
Outstanding | shares 12,563
Expiry date Apr. 27, 2027 [1]
Weighted average exercise price | $ / shares $ 2.01
November 21, 2028 [Member]  
Schedule of Derivative Liability Warrants Outstanding [Line Items]  
Outstanding | shares 75,000
Expiry date Nov. 21, 2028 [1]
Weighted average exercise price | $ / shares $ 4
[1] On April 28, 2023, the Company amended the warrant agreements for the 231,828 derivative liability warrants outstanding. The amendment removed the clause to automatically convert warrants to shares on IPO date and all warrants were given an expiry date of April 27, 2027. This led to an increase in the expected life input in the Black-Scholes model as of December 31, 2023, compared to December 31, 2022, when the Company used the expected IPO date to calculate the expected life of the warrants.